Share

What we heard at HLTH: George Carroll on HealthTech growth and hiring for 2027

What we heard at HLTH: George Carroll on HealthTech growth and hiring for 2027
Share

George Carroll, Head of SciPro USA, and Lauren Placencia, MD headed to Las Vegas for HLTH USA to catch up with the HealthTech community and hear how founders are approaching their next stage of growth.

Lauren also took HealthTech Happy Hour onto the conference floor, recording conversations with people building across the sector. For her, returning for a second year felt like coming home, with familiar faces to reconnect with and plenty of new people to meet.

Following the conference, George shared what stood out in his conversations with founders and investors, and what those discussions could mean for businesses planning for 2027.

 

Before HLTH, you spoke about go-to-market and capital efficiency being priorities for founders. Did your conversations reinforce that, or did anything surprise you?

It definitely reinforced the go-to-market point, but the biggest surprise was the appetite to invest.

I spoke to a lot of VCs and investors, and compared with recent years, there’s far more willingness to back companies before they have revenue. Some still want to see $1 million in annual recurring revenue before they commit, but that’s no longer the universal bar. One investor I met will back founders with no revenue at all and can even incubate the company.

Capital efficiency still matters, but founders with a strong team and a clear problem have more options than they did 12 to 18 months ago.

 

What milestones are HealthTech businesses working towards in 2027, and how are those shaping the people or expertise they need next?

For a lot of founders, 2027 is about proving one thing well: landing the first anchor customers, closing a funding round or securing a licensing or partnership deal that unlocks the next stage.

I met several companies that were one deal away from being able to kick on. That shapes hiring in a very specific way. Early on, they need a small number of high-impact people who can sell into one market and establish proof of concept.

We’re also seeing more interest in fractional and contract talent, so companies can bring in senior expertise without committing too much runway before they reach that milestone.

 

Was there a conversation that changed how you thought about a hiring or growth challenge? What stood out?

What stood out was how many platforms could serve multiple markets. The same product could sell to payers, providers and pharma or biotech. That’s a strength, but it’s also a trap.

The companies with the clearest momentum had picked one market, proved it worked and built a revenue stream before looking elsewhere. Others were still trying to define their focus, and you could see it in their hiring plans: they wanted to hire for three markets at once.

It changed how I think about the first commercial hire. The right person depends entirely on which market you’re committing to first, so that decision has to come before the hire.

 

Based on what you heard at HLTH, what should an early-stage HealthTech founder be thinking about as they plan for the year ahead?

Three things.

First, focus. Pick one buyer, prove it and build revenue before expanding. Hire for that market, rather than every market you might reach one day.

Second, think about where you fit in a consolidating market. There are some excellent businesses whose platforms would sit naturally alongside another company’s and offer its customers something new. I expect a lot of mergers and acquisitions over the next six to 18 months, so know who your natural partners and potential acquirers are.

Third, watch the AI and wearables space closely. Oura’s agreement to acquire Counsel Health for $625 million in cash shows how quickly wearables are moving into care itself.

I don’t think wearables will replace primary care doctors, but I expect them to increasingly inform clinical decisions. Founders working in that space need to be thinking now about data reliability, clinical credibility and the role AI will play.

 

Continuing the conversations

Thank you to everyone who made time to speak with George and Lauren at HLTH. We’ll be sharing more of Lauren’s HealthTech Happy Hour interviews, hearing directly from the people building products and businesses across the community.

If you didn’t get a chance to meet in Vegas, we’d still love to hear what you’re working towards.

Speak with our team about your next milestone and the expertise you need to reach it.

Planning your HealthTech team for 2027?
banner

Ready to find a new role?
Or, looking for fresh talent?

We are a trusted partner for every step from Discovery through to Development. So, no matter where you are in your journey, we're here to help you make a difference. We are a trusted partner for every step from Discovery through to Development. So, no matter where you are in your journey, we're here to help you make a difference.